B
Bioscience Animal Health PCL
SET:BIS
Bioscience Animal Health PCL
SET:BIS
Price:
2.06
THB
0.98%
Market Closed
Market Cap:
฿646.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
C
|
Cathay Consolidated Inc
TWSE:1342
|
TW |
|
Jiangsu Dagang Co Ltd
SZSE:002077
|
CN |
|
V
|
VEON Ltd
LSE:0RO7
|
NL |
|
M
|
MoneyGram International Inc
F:9M1N
|
US |
|
R
|
Ritamix Global Ltd
HKEX:1936
|
MY |
|
D
|
DPC Dash Ltd
HKEX:1405
|
CN |
|
Kombinat Yuzhuralnikel' PAO
MOEX:UNKL
|
RU |
|
Prostar Holdings Inc
XTSX:MAPS
|
US |
|
R
|
Renco Holdings Group Ltd
HKEX:2323
|
HK |
|
B
|
Benchmark Bankshares Inc
OTC:BMBN
|
US |
|
S
|
Sino Grandness Food Industry Group Ltd
SGX:T4B
|
CN |
|
A
|
Aqua Bio Technology ASA
OSE:ABTEC
|
NO |
|
P
|
Pesona Metro Holdings Bhd
KLSE:PESONA
|
MY |
Income Statement
Earnings Waterfall
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Income Statement
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Currency: THB
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
|
| Revenue |
2 268
N/A
|
2 327
+3%
|
2 412
+4%
|
2 450
+2%
|
2 486
+1%
|
2 392
-4%
|
2 324
-3%
|
2 337
+1%
|
2 294
-2%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(1 962)
|
(2 013)
|
(2 080)
|
(2 104)
|
(2 129)
|
(2 036)
|
(1 978)
|
(1 976)
|
(1 926)
|
|
| Gross Profit |
306
N/A
|
315
+3%
|
333
+6%
|
346
+4%
|
357
+3%
|
355
0%
|
346
-3%
|
361
+4%
|
367
+2%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(244)
|
(251)
|
(265)
|
(269)
|
(272)
|
(260)
|
(251)
|
(258)
|
(262)
|
|
| Selling, General & Administrative |
(265)
|
(264)
|
(279)
|
(284)
|
(283)
|
(287)
|
(291)
|
(296)
|
(297)
|
|
| Other Operating Expenses |
22
|
13
|
15
|
15
|
12
|
25
|
40
|
36
|
35
|
|
| Operating Income |
62
N/A
|
64
+3%
|
68
+7%
|
77
+13%
|
86
+11%
|
95
+11%
|
95
0%
|
103
+8%
|
105
+2%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Pre-Tax Income |
60
N/A
|
62
+3%
|
66
+7%
|
75
+14%
|
83
+10%
|
93
+11%
|
92
0%
|
99
+8%
|
103
+3%
|
|
| Net Income | ||||||||||
| Tax Provision |
(12)
|
(12)
|
(14)
|
(15)
|
(17)
|
(22)
|
(21)
|
(22)
|
(23)
|
|
| Income from Continuing Operations |
48
|
50
|
53
|
60
|
66
|
70
|
72
|
77
|
80
|
|
| Income to Minority Interest |
(3)
|
(2)
|
(2)
|
(2)
|
(4)
|
(7)
|
(7)
|
(7)
|
(7)
|
|
| Net Income (Common) |
45
N/A
|
48
+6%
|
51
+7%
|
57
+13%
|
61
+7%
|
62
+1%
|
65
+5%
|
70
+7%
|
72
+4%
|
|
| EPS (Diluted) |
0.14
N/A
|
0.15
+7%
|
0.16
+7%
|
0.18
+12%
|
0.19
+6%
|
0.19
N/A
|
0.21
+11%
|
0.22
+5%
|
0.23
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
